Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort.

"Conflicts of interest There are no conflicts of interest."

"Funding: This project has received funding from Wellcome (069598/Z/02/Z), European Union's Horizon 2020 Research and Innovation program under grant agreement no. 681137 (to K.J.D. and I.H.), the Medical Research Council (MRC) (to K.J.D. [MR/K024426/1]), the, Rosetrees Trust (to K.J.D., M686) and Fondation Dormeur, Vaduz (to K.J.D). This research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas’ NHS Foundation Trust and King's College London and/or the NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. L.A.G. were supported by the King's Bioscience Institute and the Guy's and St Thomas’ Charity Prize Ph.D. Programme in Biomedical and Translational Science. J.M.M. received a personal 80 : 20 research grant from Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017–2021."